1-20 of 103
Andriy Derkach
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparing the accuracy of natural language processing labelling versus manual chart review and ICD-10 codes to identify bleeding events in patients with cancer

Free
Thomas Fusillo, Avi Leader, Rohan Singh, Andriy Derkach, Kayan Irani, Bhaskar Bose, Helen Ajufo, Adam Schoenfeld, Simon Mantha, Jeffrey Zwicker
Journal: Blood
Blood (2025) 146 (Supplement 1): 6114.
https://doi.org/10.1182/blood-2025-6114
Published: 2025
Journal Articles

Obesity is Associated with Higher Risk Disease State and Reduced Overall Survival in Females with MDS

Free
Joshua Weinreb, Andriy Derkach, Omar Abdel-Wahab, Eytan Stein
Journal: Blood
Blood (2025) 146 (Supplement 1): 7364.
https://doi.org/10.1182/blood-2025-7364
Published: 2025
Journal Articles

Lenalidomide-related diarrhea is associated with gut microbiota dysbiosis and disruption of the bile acid pool

Free
Kevin Miller, Teng Fei, Ruben Ramos, Ana Catarina Gradissimo De Oliveira, Jennifer Haber, Minsu Jaun, Francesca Castro, Andriy Derkach, Issam Hamadeh, Kylee Maclachlan, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Sridevi Rajeeve, Francesco Maura, Maximillian Merz, Hamza Hashmi, Ross Firestone, Eric Jurgens, Gunjan Shah, Michael Scordo, Heather Landau, Jonathan Peled, Sergio Giralt, Neha Korde, Saad Usmani, Urvi Shah, Alexander Lesokhin
Journal: Blood
Blood (2025) 146 (Supplement 1): 2233.
https://doi.org/10.1182/blood-2025-2233
Published: 2025
Journal Articles

Incidence of arterial thromboembolism in patients with myeloproliferative neoplasms treated with anticoagulation for venous thromboembolism

Free
Antonia Chan, Rodyna Mostafa, Sangam Sangam, Andriy Derkach, Jeffrey Zwicker, Rushad Patell, Avi Leader
Journal: Blood
Blood (2025) 146 (Supplement 1): 3138.
https://doi.org/10.1182/blood-2025-3138
Published: 2025
Journal Articles

Functionally high-risk disease is associated with inferior outcomes after chimeric antigen receptor T-cell therapy for relapsed refractory multiple myeloma

Free
Tara Sebastian, Hamza Hashmi, Ross Firestone, Eric Jurgens, Sridevi Rajeeve, Tasmin Farzana, Maximilian Merz, Carlyn Tan, Kylee Maclachlan, Francesco Maura, Neha Korde, Hani Hassoun, Urvi Shah, Malin Hultcrantz, Heather Landau, Michael Scordo, Alexander Lesokhin, Andriy Derkach, David Nemirovsky, Sergio Giralt, Sham Mailankody, Saad Usmani
Journal: Blood
Blood (2025) 146 (Supplement 1): 2291.
https://doi.org/10.1182/blood-2025-2291
Published: 2025
Journal Articles

Genomic profiling identifies somatic alterations predicting thromboembolic risk in patients with lymphoma

Free
Varun Iyengar, Zachary Epstein-Peterson, Andriy Derkach, Gilles Salles, Jeffrey Zwicker, Simon Mantha
Journal: Blood
Blood (2025) 146 (Supplement 1): 19.
https://doi.org/10.1182/blood-2025-19
Published: 2025
Journal Articles

A Phase II multicenter study of minimal residual disease-guided, time-limited acalabrutinib + obinutuzumab for the initial treatment of chronic lymphocytic leukemia

Free
Meghan Thompson, Anthony Mato, Lia Palomba, Lori Leslie, Andriy Derkach, David Nemirovsky, Prioty Islam, Mark Geyer, Philip Caron, Aaron Goldberg, Anita Kumar, Alison Moskowitz, Jennifer Lue, Colette Owens, Gilles Salles, Eytan Stein, Raphael Steiner, Pallawi Torka, Lori Dahncke, Emily Ordona, Mashiyate Meem, Claire Hutzler, Miranda Harris, Monica Shah, Megha Karnam, Lauren Nogan, Caitlin Maloney, Anmol Shah, Tenzin Nyima, Colleen Dorsey, Kate Doyle, Jennifer Howgate-Klingaman, Jamila Brutus, Dianna Tyznar, Anna Lincke, Rick Wray, Tatyana Feldman, Andrew Zelenetz, Lindsey Roeker
Journal: Blood
Blood (2025) 146 (Supplement 1): 5676.
https://doi.org/10.1182/blood-2025-5676
Published: 2025
Journal Articles

Updated results from a Phase II study of minimal residual disease-guided venetoclax + obinutuzumab for the initial treatment of fit patients with chronic lymphocytic leukemia

Free
Meghan Thompson, Anthony Mato, Andrew Zelenetz, Jae Park, Mark Geyer, Andriy Derkach, David Nemirovsky, Deborah Stephens, Catherine Coombs, Prioty Islam, Christopher Jensen, Lorenzo Falchi, Lia Palomba, Anita Kumar, Gilles Salles, Eytan Stein, Jennifer Lue, Lauren Nogan, Bejal Kikani, Ryan Sutterby, Thu Quynh Nguyen, Alexandra Allen, Sumathy Sudhir, Gail Panton, Victoria Duffy, Dianna Tyznar, Jamila Brutus, Tenzin Nyima, Anmol Shah, Dhara Soni, Michael Silvestrone, Monica Shah, Miranda Harris, Megha Karnam, Claire Hutzler, Kevin David, Aaron Goldberg, Stephen Fleming, Giovanni Diaz, Habib Hamidi, Bita Fakhri, Lindsey Roeker
Journal: Blood
Blood (2025) 146 (Supplement 1): 3902.
https://doi.org/10.1182/blood-2025-3902
Published: 2025
Journal Articles

A phase II study of IDH1 inhibition with ivosidenib as maintenance therapy after ivosidenib, azacitidine, and venetoclax for Acute Myeloid Leukemia: Trial in progress

Free
Kuo-Kai Chin, Andriy Derkach, Leora Boussi, Gabrielle Melamed, Giulia Petrone, Kelly Bolton, Maher Abdul Hay, Jessica Altman, Andrew Intlekofer, Eytan Stein
Journal: Blood
Blood (2025) 146 (Supplement 1): 1690.
https://doi.org/10.1182/blood-2025-1690
Published: 2025
Journal Articles

A Phase 1/2 study of the menin inhibitor revumenib with the celmod mezigdomide in relapsed/refractory KMT2A-rearanged, NPM1-mutant, and NUP98-rearranged acute leukemias

Free
Kuo-Kai Chin, Sheng Cai, Andriy Derkach, Gabrielle Melamed, Natalie Smith, Neerav Shukla, Joshua Zeidner, Ibrahim Aldoss, Ghayas Issa, Eytan Stein
Journal: Blood
Blood (2025) 146 (Supplement 1): 1657.
https://doi.org/10.1182/blood-2025-1657
Published: 2025
Journal Articles

The outcomes of patients who are relapsed or refractory to menin inhibitors is poor with a limited overall survival

Free
Kuo-Kai Chin, Brian Ball, Yasmin Abaza, Jessica Altman, Rahul Thakur, Moiez Ali, Andriy Derkach, Mark Geyer, Aaron Goldberg, Tamanna Haque, Meghan Thompson, Jae Park, Martin Tallman, Sheng Cai, Eunice Wang, Ibrahim Aldoss, Eytan Stein
Journal: Blood
Blood (2025) 146 (Supplement 1): 39.
https://doi.org/10.1182/blood-2025-39
Published: 2025
Journal Articles

Rethinking disparity in Acute Myeloid Leukemia, a new perspective in the Asian population

Free
Agomoni Saha, Andriy Derkach, Wenbin Xiao, Eytan Stein, Ying Liu, Xin Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 38.
https://doi.org/10.1182/blood-2025-38
Published: 2025
Journal Articles

The combination of ruxolitinib and the CDK4/6 inhibitor abemaciclib demonstrates safety and efficacy in previously treated myelofibrosis patients: Results of A phase I study

Free
Jan Philipp Bewersdorf, Andriy Derkach, Amer Zeidan, Emily Burton, Katherine Kan, Marissa Giuliani, Jeetayu Biswas, Michael Mauro, Brian Chernak, Tamanna Haque, Nikolai Podoltsev, Ross Levine, Prithviraj Bose, Raajit Rampal
Journal: Blood
Blood (2025) 146 (Supplement 1): 3814.
https://doi.org/10.1182/blood-2025-3814
Published: 2025
Journal Articles

Genomics define neoplastic transformation in multiple myeloma precursor conditions

Free
Francesco Maura, P. Leif Bergsagel, Bachisio Ziccheddu, Shaji Kumar, Kylee Maclachlan, Andriy Derkach, Juan-Jose Garces, Ross Firestone, Esteban Braggio, Yan Asmann, Michael Durante, Benjamin Diamond, Marios Papadimitriou, Malin Hultcrantz, Giancarlo Castellano, Alessio Marella, Akihiro Maeda, Marta Lionetti, Antonio Matera, Stefania Pioggia, Matteo Claudio Da Vià, Claudio de Magistris, Daniel Leongamornlert, Daniel Deavila, Praneeth Reddy Sudalagunta, Rafael Renatino Canevarolo, Erin Siegel, Phaedra Agius, Jamie Teer, Andrew McPherson, Yusuke Yamashita, Ariosto Siqueira Silva, Patrick Blaney, Rachid Baz, Krina Patel, Peter Campbell, Gareth Morgan, Rafael Fonseca, Ola Landgren, Robert Orlowski, Kenneth Shain, Niccolo Bolli, Saad Usmani, Vincent Rajkumar
Journal: Blood
Blood (2025) 146 (Supplement 1): 686.
https://doi.org/10.1182/blood-2025-686
Published: 2025
Journal Articles

A phase I study of the combination of ruxolitinib and the ERK1/2 inhibitor ulixertinib in previously treated myelofibrosis patients.

Free
Chi-Joan How, Gabriela Hobbs, Aaron Gerds, Andriy Derkach, Emily Burton, Aurora Duran, Katherine Kan, Michael Mauro, Brian Chernak, Tamanna Haque, Raajit Rampal
Journal: Blood
Blood (2025) 146 (Supplement 1): 5606.
https://doi.org/10.1182/blood-2025-5606
Published: 2025
Journal Articles

Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma – final results from a randomized investigator-initiated trial

Free
Sridevi Rajeeve, Andriy Derkach, Sean Devlin, Jeannen Santos, Anna Przemielewska, Tara Sood, Francesca Castro, Thomas Atkinson, Kylee Maclachlan, Hamza Hashmi, Carlyn Tan, Neha Korde, Malin Hultcrantz, Alexander Lesokhin, Hani Hassoun, Parastoo Dahi, Michael Scordo, David Chung, Heather Landau, Gunjan Shah, Ola Landgren, Sergio Giralt, Sham Mailankody, Saad Usmani, Urvi Shah
Journal: Blood
Blood (2025) 146 (Supplement 1): 2273.
https://doi.org/10.1182/blood-2025-2273
Published: 2025
Journal Articles

Second primary malignancies in multiple myeloma: Incidence, survival and prognostic factors from a large single-center observational study

Free
Noriko Nishimura, Andriy Derkach, Kelly Barnett, Tala Shekarkhand, Issam Hamadeh, Heather Landau, Michael Scordo, Gunjan Shah, Roni Shouval, Ross Firestone, Sridevi Rajeeve, Francesco Maura, Hamza Hashmi, Maximillian Merz, Malin Hultcrantz, Neha Korde, Alexander Lesokhin, Sham Mailankody, Urvi Shah, Kylee Maclachlan, Carlyn Tan, Sergio Giralt, Saad Usmani, Hani Hassoun
Journal: Blood
Blood (2025) 146 (Supplement 1): 2213.
https://doi.org/10.1182/blood-2025-2213
Published: 2025
Journal Articles

Low dose tocilizumab for mitigation of cytokine release syndrome with bispecific antibodies in relapsed/refractory multiple myeloma

Free
Issam Hamadeh, Maximillian Merz, Andriy Derkach, Tala Shekarkhand, Alexander Lesokhin, Sham Mailankody, Malin Hultcrantz, Carlyn Tan, Hani Hassoun, Urvi Shah, Kylee Maclachlan, Sridevi Rajeeve, Hamza Hashmi, Francesco Maura, Ross Firestone, Alice Wang, Dhwani Patel, Michael Scordo, Gunjan Shah, Heather Landau, Sergio Giralt, Saad Usmani, Neha Korde
Journal: Blood
Blood (2025) 146 (Supplement 1): 2210.
https://doi.org/10.1182/blood-2025-2210
Published: 2025
Journal Articles

Clonal persistence and early cooperative mutations shape transformation in myelofibrosis

Free
Noushin Farnoud, Kamal Menghrajani, Paola Guglielmelli, Christopher Famulare, Erin McGovern, Giuseppe Gaetano Loscocco, Andriy Derkach, Andrew Dunbar, Naseema Gangat, Vikas Gupta, Andrea Arruda, Taghi Manshouri, Srdan Verstovsek, Andrew Kuykendall, Vincent Ho, Auro Viswabandya, Joachim Deeg, Thomas Monahan, Tania Jain, Jeanne Palmer, Alla Keyzner, Aaron Gerds, Alexandra Gomez-Arteaga, Nikolai Podoltsev, Roni Tamari, Helen Ajufo, Satyajit Kosuri, Haris Ali, Idoroenyi Amanam, Jordan Chervin, Minal Patel, Jesús Gutiérrez-Abril, Sarun Sereewattanawoot, Juan Arango Ossa, Francesco Passamonti, Francesco Maura, Maymona Abdelmagid, Ahmed Abdelrheem, Yassin Bashir, Muhammad Yousuf, Animesh Pardanani, Kapila Viges, David Shoultz, Rick Winneker, Omar Abdel-Wahab, John Mascarenhas, Ronald Hoffman, Ross Levine, Elli Papaemmanuil, Alessandro Vannucchi, Ayalew Tefferi, Raajit Rampal
Journal: Blood
Blood (2025) 146 (Supplement 1): 2046.
https://doi.org/10.1182/blood-2025-2046
Published: 2025
Journal Articles

Belantamab mafodotin, nirogacestat, and pomalidomide in patients with relapsed/refractory multiple myeloma

Free
Malin Hultcrantz, Hani Hassoun, Neha Korde, Carlyn Tan, Sergio Giralt, Alexander Lesokhin, Kylee Maclachlan, Dhwani Patel, Urvi Shah, Sridevi Rajeeve, Hamza Hashmi, Andriy Derkach, Ross Firestone, Linh Tran, Meredith Hyland, Kazunori Murata, Kevin Herrera, Karlo Perica, Saad Usmani, Sham Mailankody
Journal: Blood
Blood (2025) 146 (Supplement 1): 4060.
https://doi.org/10.1182/blood-2025-4060
Published: 2025